ArticleAmerican journal of respiratory and critical care medicine2017

Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.

I-Shou Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.